Skip to main content
Log in

T5 Group Bacteriophages as Potential Phage Therapy Agents

  • SHORT COMMUNICATIONS
  • Published:
Microbiology Aims and scope Submit manuscript

Abstract

The T5 group bacteriophages, which infect a number of enterobacterial species and strains, are useful objects for obtaining therapeutic phage preparations with broad specificity. The present work considers the biological properties of T5-related phages responsible for their ability to infect a broad spectrum of bacterial strains in spite of a limited number of known phage receptor proteins. Ability of bacteriophages to recognize bacterial O-antigens specifically enhances their capacity for infection and increases the therapeutic potential of the T5 phages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

REFERENCES

  1. Broeker, N.K. and Barbirz, S., Not a barrier but a key: how bacteriophages exploit host’s O-antigen as an essential receptor to initiate infection, Mol. Microbiol., 2017, vol. 105, pp. 353–357.

    Article  CAS  Google Scholar 

  2. DebRoy, C., Fratamico, P.M., and Roberts, E., Molecular serogrouping of Escherichia coli,Anim. Health Res. Rev., 2018, vol. 19, pp. 1–16. https://doi.org/10.1017/S1466252317000093

  3. Flayhan, A., Wien, F., Paternostre, M., Boulanger, P., and Breyton, C., New insights into pb5, the receptor binding protein of bacteriophage T5, and its interaction with its Escherichia coli receptor FhuA, Biochimie, 2012, vol. 94, pp. 1982–1989.

    Article  CAS  Google Scholar 

  4. Golomidova, A.K., Kulikov, E.E., Babenko, V.V., Ivanov, P.A., Prokhorov, N.S., and Letarov, A.V., Escherichia coli bacteriophage Gostya9, representing a new species within the genus T5 virus, Arch. Virol., 2019, vol. 164, pp. 879–884. https://doi.org/10.1007/s00705-018-4113-2

    Article  CAS  PubMed  Google Scholar 

  5. Golomidova, A.K., Kulikov, E.E., Prokhorov, N.S., Guerrero-Ferreira, R.C., Knirel, Y.A., Kostryukova, E.S., Tarasyan, K.K., and Letarov, A.V., Branched lateral tail fiber organization in T5-like bacteriophages DT57C and DT571/2 is revealed by genetic and functional analysis, Viruses, 2016, vol. 8. pii: E26. https://doi.org/10.3390/v8010026

    Article  CAS  PubMed  Google Scholar 

  6. Grover, J.M., Luna, A.J., Wood, T.L., Chamakura, K.R., and Kuty Everett, G.F., Complete genome of Salmonella enterica serovar Typhimurium T5-like Siphophage Stitch, Genome Announc., 2015, vol. 3. e01435-14. https://doi.org/10.1128/genomeA.01435-14

    Article  PubMed  PubMed Central  Google Scholar 

  7. Heller, K. and Braun, V., Polymannose O-antigens of Escherichia coli, the binding sites for the reversible adsorption of bacteriophage T5+ via the L-shaped tail fibers, J. Virol., 1982, vol. 41, pp. 222–227.

    Article  CAS  Google Scholar 

  8. Kulikov, E.E., Golomidova, A.K., Prokhorov, N.S., Ivanov, P.A., and Letarov, A.V., High-throughput LPS profiling as a tool for revealing of bacteriophage infection strategies, Sci. Rep., 2019, vol. 9, p. 2958.

    Article  Google Scholar 

  9. McCorquodale, D.J. and Warner, H.R., Bacteriophage T5 and related phages, in The Bacteriophages, Calendar, R., Ed., Boston: Springer, 1988, vol. 1, pp. 439–475.

    Google Scholar 

  10. Niu, Y.D., Stanford, K., Kropinski, A.M., Ackermann, H.W., Johnson, R.P., She, Y.M., Ahmed, R., Villegas, A., and McAllister, T.A., Genomic, proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7, PLoS One, 2012, vol. 7, p. e34585.

    Article  CAS  Google Scholar 

  11. Piya, D., Xie, Y., Hernandez Morales, A.C., and Kuty Everett, G.F., Complete genome sequence of Salmonella enterica serovar Typhimurium siphophage Shivani, Genome Announc., 2015, vol. 3. https://doi.org/10.1128/genomeA.01443-14

  12. Raya, R.R., Oot, R.A., Moore-Maley, B., Wieland, S., Callaway, T.R., Kutter, E.M., and Brabban, A.D., Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts, Bacteriophage, 2011, vol. 1, pp. 15–24.

    Article  Google Scholar 

  13. Sváb, D., Falgenhauer, L., Rohde, M., Szabó, J., Chakraborty, T., and Tóth, I., Identification and characterization of T5-like bacteriophages representing two novel subgroups from food products, Front Microbiol., 2018, vol. 9, p. 202. https://doi.org/10.3389/fmicb.2018.00202

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The work to determine the spectrum of host strains of the Proteus spp. bacteriophage PM135 was performed as part of the project no. 18-29-08015, Russian Foundation for Basic Research. The search and research for new hosts for the DT57C/DT571/2 and Gostya9 coliphages was supported by the Russian Science Foundation, project no. 15-15-00134P.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. K. Golomidova.

Ethics declarations

The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.

Additional information

Translated by E. Babchenko

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kulikov, E.E., Golomidova, A.K., Morozova, V.V. et al. T5 Group Bacteriophages as Potential Phage Therapy Agents. Microbiology 88, 769–772 (2019). https://doi.org/10.1134/S0026261719060067

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026261719060067

Keywords:

Navigation